Laurence Mévellec
-
- Click Chemistry and Applications 3
- Asymmetric Synthesis and Catalysis 2
-
- PI3K/AKT/mTOR signaling in cancer 2
- DNA and Nucleic Acid Chemistry 2
-
- Cancer-related Molecular Pathways 2
-
- Liver physiology and pathology 3
-
- Cancer Mechanisms and Therapy 3
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- F. HuetCyrille LescopMichel EversJean-Pierre RobinJorge VialardGilles DujardinRobert DhalDara L. Aisner
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Laurence Mévellec
19 papers receiving 307 citations
Peers
Comparison fields: 5 of 41
- Organic Chemistry 146
- Molecular Biology 173
- Oncology 68
- Hepatology 18
- Pulmonary and Respiratory Medicine 68
Countries citing papers authored by Laurence Mévellec
This map shows the geographic impact of Laurence Mévellec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Mévellec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Mévellec more than expected).
Fields of papers citing papers by Laurence Mévellec
This network shows the impact of papers produced by Laurence Mévellec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Mévellec. The network helps show where Laurence Mévellec may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laurence Mévellec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 12 | |
| 3 | 2018 | 2 | |
| 4 | 2016 | 2 | |
| 5 | 2014 | 8 | |
| 6 | 2014 | 1 | |
| 7 | 2014 | 65 | |
| 8 | 2010 | 4 | |
| 9 | JNJ-38877605: a selective Met kinase inhibitor inducing regression of Met-driven tumor models. | 2008 | 20 |
| 10 | 2007 | 7 | |
| 11 | 2003 | 13 | |
| 12 | 2003 | 19 | |
| 13 | 2001 | 31 | |
| 14 | 2000 | 9 | |
| 15 | 1999 | 42 | |
| 16 | 1997 | 14 | |
| 17 | 1996 | 29 | |
| 18 | 1995 | 19 | |
| 19 | 1994 | 15 |
About Laurence Mévellec
Laurence Mévellec is a scholar working on Hepatology, Process Chemistry and Technology and Pharmaceutical Science, having authored 19 papers that have together received 313 indexed citations. Recurring topics across this work include Click Chemistry and Applications (3 papers), Cancer Mechanisms and Therapy (3 papers), Liver physiology and pathology (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Asymmetric Synthesis and Catalysis (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Cancer-related Molecular Pathways (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Organic Chemistry (146 citations), Molecular Biology (173 citations) and Oncology (68 citations). Laurence Mévellec has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include F. Huet, Cyrille Lescop, Michel Evers, Jean-Pierre Robin, Jorge Vialard, Gilles Dujardin, Robert Dhal, Dara L. Aisner, Rafał Dziadziuszko and Paolo M. Comoglio. Their work appears in journals such as Blood, Biochemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.